27 February - 4 March 2016
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Recommendations for Tysabri and PML
The European Medicines Agency (EMA) has confirmed its recommendation on closer monitoring of people on Tysabri at risk of the brain infection PML. People who are JC virus positive, have been on Tysabri for two years or more and been on immunosuppressant drugs should only continue treatment "if benefits outweigh the risks".
MS Trust link: Tysabri (natalizumab)
Neurological services in Scotland
A Sue Ryder campaign highlights the gaps in provision in neurological services in Scotland, particularly the number of younger people in care homes for older people.
Pregnancy and risk of progression
Italian research studied mothers with MS - one group who had had one pregnancy and another who had more than one. There was no difference between groups in disability measures over seven years, suggesting having multiple pregnancies doesn't after progression
Source: MS News Today
MS Trust link: Pregnancy